Year: 2015

Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center. Read More

After a bout with bladder cancer, Ballard serves as a member of the Vanderbilt-Ingram Cancer Center Young Ambassadors. Read More

With temperatures holding steady in the upper 90s and even reaching 100 degrees this week, doctors at Vanderbilt University Medical Center are urging Middle Tennesseans to take extra precautions to avoid heat-related illnesses. Read More

All of the candidates running in the Aug. 6 Nashville election are invited to stump for votes at a July 16 indoor picnic for the Vanderbilt community. Read More

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production. Read More

In his effort to develop better prosthetic limbs, Karl Zelik had to start with deciphering more clearly how muscles function in walking. His path not only led to a better way of quantifying human locomotion, but also to the discovery that muscles around the hip and in the foot are more important to walking than previously thought. Read More

A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair. Read More

The AmericasBarometer survey is the only scientifically rigorous comparative survey that covers all of North, Central, and South America, as well as a significant number of countries in the Caribbean. Read More

Katrina Markoff, BA’97, co-founded the pioneering boutique chocolate label Vosges Haut-Chocolat. Read More

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder. Read More

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given. Read More

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine. Read More

Gayla Harvey has been named senior vice president of Revenue Cycle Services and Payer Strategy for Vanderbilt University Medical Center. Read More

A team of Vanderbilt University Medical Center project managers has been working in recent months to train staff and transition clinics to a new medical coding and reporting system set to go into effect later this year. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research. Read More

Vanderbilt University’s F. Peter (Fred) Guengerich, Ph.D., has been named interim editor-in-chief of the Journal of Biological Chemistry (JBC). Read More

CS 2.0 started with McKesson announcing that the Horizon suite of software used at VUMC would no longer be supported in 2018. We are using this announcement as a motivator to evaluate all our systems and plan for what our patients, our staff and our faculty need in the future. Read More

Before winning NBC’s The Sing Off last December with his fellow Melodores, Ted Moock, BS’15, had already been cast to play a Treblemaker in the movie Pitch Perfect 2, currently out in theatres. Read More

As a gastroenterologist, Christopher Lind, M.D., says he is often the “butt” of jokes, but few people truly appreciate the role the gut plays in their happiness. Read More

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus. Read More